{"id":"NCT04461015","sponsor":"Adrian Vella","briefTitle":"The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans","officialTitle":"The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-10-14","primaryCompletion":"2021-07-30","completion":"2022-01-06","firstPosted":"2020-07-08","resultsPosted":"2022-06-21","lastUpdate":"2022-06-21"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"BASIC_SCIENCE"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"0.4mU Insulin followed by withdrawal period followed by 0.8mU study","otherNames":["0.4 then 0.8"]},{"type":"DRUG","name":"0.8mU Insulin followed by withdrawal period followed by 0.4mU study","otherNames":["0.8 then 0.4"]}],"arms":[{"label":"0.4mU Insulin","type":"OTHER"},{"label":"0.8mU Insulin","type":"OTHER"}],"summary":"The purpose of this research is to help understand the relative importance of changes in insulin secretion (which lowers glucose) and changes in glucagon (which raises glucose) to regulate metabolism and the body's ability to make glucose.","primaryOutcome":{"measure":"Endogenous Glucose Production (EGP)","timeFrame":"It will be quantified at 90, 180 and 270 minutes for the study with 0.4mU insulin infusion and compared to values obtained for the study with 0.8mU insulin infusion at the same timepoints","effectByArm":[{"arm":"0.4mU Insulin","deltaMin":4.99,"sd":0.53},{"arm":"0.8mU Insulin","deltaMin":5.02,"sd":0.74}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.mayo.edu/research/clinical-trials"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Phlebitis","Nausea"]}}